Revalia Bio Revenue and Competitors

New Haven, CT USA

Location

#9796

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Revalia Bio's estimated annual revenue is currently $5.9M per year.(i)
  • Revalia Bio's estimated revenue per employee is $190,000
  • Revalia Bio's total funding is $12M.

Employee Data

  • Revalia Bio has 31 Employees.(i)
  • Revalia Bio grew their employee count by 72% last year.

Revalia Bio's People

NameTitleEmail/Phone
1
Co-Founder and CEOReveal Email/Phone
2
Chief Operating Officer & Co-founderReveal Email/Phone
3
Co-Founder & CSOReveal Email/Phone
4
Co-Founder & Chief Medical OfficerReveal Email/Phone
5
Co-Founder & Chief Research Operations OfficerReveal Email/Phone
6
Co-Founder & Chief Operating OfficerReveal Email/Phone
7
Co-Founder & Chief Culture & Growth OfficerReveal Email/Phone
8
Chief Research Operations OfficerReveal Email/Phone
9
Principal Scientist, Data GenerationReveal Email/Phone
10
Senior Organ Perfusion ResearcherReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.2M10%N/AN/A
#2
$3.3M21-25%N/AN/A
#3
$9.8M81-10%N/AN/A
#4
$1.7M11450%N/AN/A
#5
$20.3M131-23%N/AN/A
#6
$5.4M35-22%N/AN/A
#7
$2M1344%N/AN/A
#8
$2.8M1820%N/AN/A
#9
$0.3M40%N/AN/A
#10
$3.6M23-12%N/AN/A
Add Company

What Is Revalia Bio?

Revalia Bio is a forward-thinking technology startup revolutionizing drug discovery and development with a human-centric approach. We leverage critical human data to create innovative solutions that make drug discovery more accurate, efficient, and humane.\n\nOur groundbreaking “Human Organ Trials” provide deep insights into human biology, enabling rapid and agile drug development. These trials allow us to predict clinical outcomes faster, safer, and more cost-effectively than traditional methods, transforming how drugs are developed.\n\nUnlike traditional AI-driven drug development, which relies on limited data, our Human Organ Trials bridge the gap between preclinical testing and first-in-human trials, offering a clear path that aligns with the FDA's vision to modernize drug development.\n\nAt Revalia Bio, we are committed to mitigating the risks of drug development, accelerating the creation of safer, more effective therapies, and shortening clinical trial timelines from over a decade to less than a month. Our mission is to meet the urgent need for innovative approaches that improve patient outcomes, reduce costs, and ultimately save lives.

keywords:N/A

$12M

Total Funding

31

Number of Employees

$5.9M

Revenue (est)

72%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.5M313%N/A
#2
$4.3M317%N/A
#3
$5.1M3119%N/A
#4
$6.7M3129%N/A
#5
$6.7M31-6%N/A